Evans Sue M, Millar Jeremy L, Moore Caroline M, Lewis John D, Huland Hartwig, Sampurno Fanny, Connor Sarah E, Villanti Paul, Litwin Mark S
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
William Buckland Radiotherapy Centre, Alfred Hospital, Melbourne, Victoria, Australia.
BMJ Open. 2017 Nov 28;7(11):e017006. doi: 10.1136/bmjopen-2017-017006.
Globally, prostate cancer treatment and outcomes for men vary according to where they live, their race and the care they receive. The TrueNTH Global Registry project was established as an international registry monitoring care provided to men with localised prostate cancer (CaP).
Sites with existing CaP databases in Movember fundraising countries were invited to participate in the international registry. In total, 25 Local Data Centres (LDCs) representing 113 participating sites across 13 countries have nominated to contribute to the project. It will collect a dataset based on the International Consortium for Health Outcome Measures (ICHOM) standardised dataset for localised CaP.
A governance strategy has been developed to oversee registry operation, including transmission of reversibly anonymised data. LDCs are represented on the Project Steering Committee, reporting to an Executive Committee. A Project Coordination Centre and Data Coordination Centre (DCC) have been established. A project was undertaken to compare existing datasets, understand capacity at project commencement (baseline) to collect the ICHOM dataset and assist in determining the final data dictionary. 21/25 LDCs provided data dictionaries for review. Some ICHOM data fields were well collected (diagnosis, treatment start dates) and others poorly collected (complications, comorbidities). 17/94 (18%) ICHOM data fields were relegated to non-mandatory fields due to poor capture by most existing registries. Participating sites will transmit data through a web interface biannually to the DCC.
Recruitment to the TrueNTH Global Registry-PCOR project will commence in late 2017 with sites progressively contributing reversibly anonymised data following ethical review in local regions. Researchers will have capacity to source deidentified data after the establishment phase. Quality indicators are to be established through a modified Delphi approach in later 2017, and it is anticipated that reports on performance against quality indicators will be provided to LDCs.
在全球范围内,男性前列腺癌的治疗方法和治疗结果因居住地、种族以及所接受的治疗而有所不同。TrueNTH全球注册项目是作为一个国际注册机构而设立的,用于监测为局限性前列腺癌(CaP)男性患者提供的治疗。
在“蓄须月”筹款国家中拥有现有CaP数据库的机构被邀请参与该国际注册项目。总共有25个本地数据中心(LDC)代表13个国家的113个参与机构提名参与该项目。它将基于国际健康结局测量联盟(ICHOM)的局限性CaP标准化数据集收集一个数据集。
已制定了一项治理策略来监督注册项目的运作,包括传输可逆向匿名化的数据。LDC在项目指导委员会中占有席位,并向执行委员会汇报。已设立了一个项目协调中心和一个数据协调中心(DCC)。开展了一个项目来比较现有数据集,了解项目启动时(基线)收集ICHOM数据集的能力,并协助确定最终的数据字典。25个LDC中有21个提供了数据字典以供审查。一些ICHOM数据字段收集情况良好(诊断、治疗开始日期),而其他字段收集情况不佳(并发症、合并症)。由于大多数现有注册机构的捕获情况不佳,94个ICHOM数据字段中有17个(18%)被列为非必填字段。参与机构将每半年通过网络界面向DCC传输一次数据。
TrueNTH全球注册-PCOR项目的招募工作将于2017年末开始,各机构将在当地进行伦理审查后逐步提供可逆向匿名化的数据。在建立阶段之后,研究人员将能够获取去标识化的数据。质量指标将于2017年晚些时候通过改良的德尔菲法确定,预计将向LDC提供关于质量指标绩效的报告。